Stanislas Veillet

633 total citations
24 papers, 370 citations indexed

About

Stanislas Veillet is a scholar working on Molecular Biology, Ophthalmology and Physiology. According to data from OpenAlex, Stanislas Veillet has authored 24 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Ophthalmology and 5 papers in Physiology. Recurrent topics in Stanislas Veillet's work include Retinal Diseases and Treatments (6 papers), Antioxidant Activity and Oxidative Stress (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Stanislas Veillet is often cited by papers focused on Retinal Diseases and Treatments (6 papers), Antioxidant Activity and Oxidative Stress (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Stanislas Veillet collaborates with scholars based in France, United States and Brazil. Stanislas Veillet's co-authors include René Lafont, Waly Dioh, Pierre J. Dilda, Laurence Dinan, Mathilde Latil, Jean‐François Huneau, Annie Quignard‐Boulangé, Daniel Tomé, Dominique Hermier and Patrick C. Even and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Theoretical and Applied Genetics.

In The Last Decade

Stanislas Veillet

23 papers receiving 350 citations

Peers

Countries citing papers authored by Stanislas Veillet

Since Specialization

Citations

This map shows the geographic impact of Stanislas Veillet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislas Veillet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislas Veillet more than expected).

Fields of papers citing papers by Stanislas Veillet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanislas Veillet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislas Veillet. The network helps show where Stanislas Veillet may publish in the future.

Co-authorship network of co-authors of Stanislas Veillet

This figure shows the co-authorship network connecting the top 25 collaborators of Stanislas Veillet. A scholar is included among the top collaborators of Stanislas Veillet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanislas Veillet. Stanislas Veillet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modulation of the renin-angiotensin system against COVID-19: A path forward? 2025 ·International Journal of Infectious Diseases ·Serge Camelo, Waly Dioh, J. Pedro Teixeira, Laurence W. Busse, Girish B. Nair, Gaëtan Plantefève, Capucine Morélot-Panzini, Suzana Margareth Lobo, Wesley H. Self, Sean P. Collins, Rob van Maanen, Stanislas Veillet	0
2	Characterizing sarcopenia and sarcopenic obesity in patients aged 65 years and over, at risk of mobility disability: a multicenter observational trial (SARA-OBS) 2025 ·BMC Geriatrics ·Roger A. Fielding, Yves Rolland, Olivier Bruyère, Moı̈se Desvarieux, Lorenzo M. Donini, Raffaele Antonelli Incalzi, Maurizio Muscaritoli, Achille Tchalla, Marc Bonnefoy, Mariangela Rondanelli, Rob van Maanen, Jean Mariani, (unknown), Susanna Del Signore, Cendrine Tourette, Waly Dioh, Stanislas Veillet	1
3	RAR Inhibitors Display Photo-Protective and Anti-Inflammatory Effects in A2E Stimulated RPE Cells In Vitro through Non-Specific Modulation of PPAR or RXR Transactivation 2024 ·International Journal of Molecular Sciences ·Valérie Fontaine, (unknown), (unknown), (unknown), (unknown), José‐Alain Sahel, Serge Picaud, Stanislas Veillet, René Lafont, Mathilde Latil, Pierre J. Dilda, Serge Camelo	1
4	A Phase 1 study for safety and pharmacokinetics of BIO101 (20‐hydroxyecdysone) in healthy young and older adults 2023 ·Journal of Cachexia Sarcopenia and Muscle ·Waly Dioh, Cendrine Tourette, Susanna Del Signore, (unknown), (unknown), (unknown), Pierre J. Dilda, René Lafont, Stanislas Veillet	17
5	Anti-Inflammatory Effects and Photo- and Neuro-Protective Properties of BIO203, a New Amide Conjugate of Norbixin, in Development for the Treatment of Age-Related Macular Degeneration (AMD) 2023 ·International Journal of Molecular Sciences ·Valérie Fontaine, (unknown), Laurence Dinan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mathilde Latil, Stanislas Veillet, José‐Alain Sahel, René Lafont, Pierre J. Dilda, Serge Camelo	4
6	BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice 2023 ·Journal of Cachexia Sarcopenia and Muscle ·Maria Serova, (unknown), Robin Deloux, (unknown), Stanislas Veillet, René Lafont, Pierre J. Dilda, Mathilde Latil	10
7	BIOPHYTIS BIO101 IN SARCOPENIA: UPDATE ON THE SARA PROGRAM: FROM SARA-INT TOWARDS THE PHASE 3 STUDY 2022 ·Innovation in Aging ·Cendrine Tourette, Waly Dioh, (unknown), Jean Mariani, (unknown), (unknown), Stanislas Veillet	3
8	Ecdysteroid metabolism in mammals: The fate of ingested 20-hydroxyecdysone in mice and rats 2021 ·The Journal of Steroid Biochemistry and Molecular Biology ·Laurence Dinan, (unknown), (unknown), (unknown), Ahmed Bakrim, (unknown), Jean‐Pierre Girault, Cendrine Tourette, Waly Dioh, Pierre J. Dilda, Stanislas Veillet, René Lafont	13
9	Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients 2021 ·Drug Discovery Today ·Mathilde Latil, Serge Camelo, Stanislas Veillet, René Lafont, Pierre J. Dilda	20
10	20-Hydroxyecdysone, from Plant Extracts to Clinical Use: Therapeutic Potential for the Treatment of Neuromuscular, Cardio-Metabolic and Respiratory Diseases 2021 ·Biomedicines ·Laurence Dinan, Waly Dioh, Stanislas Veillet, René Lafont	54
11	20-Hydroxyecdysone activates the protective arm of the RAAS via the MAS receptor 2021 ·Journal of Molecular Endocrinology ·René Lafont, Maria Serova, (unknown), (unknown), (unknown), Laurence Dinan, Stanislas Veillet, Mathilde Latil, Waly Dioh, Pierre J. Dilda	27
12	A2E-induced inflammation and angiogenesis in RPE cells in vitro are modulated by PPAR-α, -β/δ, -γ, and RXR antagonists and by norbixin 2021 ·Aging ·Valérie Fontaine, (unknown), (unknown), (unknown), (unknown), (unknown), Mathilde Latil, José‐Alain Sahel, Stanislas Veillet, Pierre J. Dilda, René Lafont, Serge Camelo	16
13	Beyond AREDS Formulations, What Is Next for Intermediate Age-Related Macular Degeneration (iAMD) Treatment? Potential Benefits of Antioxidant and Anti-inflammatory Apocarotenoids as Neuroprotectors 2020 ·Oxidative Medicine and Cellular Longevity ·Serge Camelo, Mathilde Latil, Stanislas Veillet, Pierre J. Dilda, René Lafont	19
14	P.149The MYODA operational seamless clinical trial design phase I to III: a new approach for rare diseases to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of BIO101 (MAS activator) in paediatric patients with a genetically confirmed diagnosis of Duchenne muscular dystrophy 2019 ·Neuromuscular Disorders ·(unknown), Waly Dioh, Pierre J. Dilda, René Lafont, Stanislas Veillet, T. Voit, (unknown)	1
15	P.370BIO101 demonstrates combined beneficial effects on muscle and motor neurons in a mouse model of severe spinal muscular atrophy 2019 ·Neuromuscular Disorders ·Mathilde Latil, (unknown), S Cottin, René Lafont, Stanislas Veillet, Pierre J. Dilda, Frédéric Charbonnier, Olivier Biondi	1
16	Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo 2016 ·PLoS ONE ·Valérie Fontaine, (unknown), Elena Brazhnikova, Laëtitia Lesage, (unknown), (unknown), (unknown), Pierre-Paul Elena, José‐Alain Sahel, Stanislas Veillet, René Lafont	17
17	Quinoa extract enriched in 20-hydroxyecdysone affects energy homeostasis and intestinal fat absorption in mice fed a high-fat diet 2014 ·Physiology & Behavior ·(unknown), Patrick C. Even, René Lafont, Waly Dioh, Stanislas Veillet, Daniel Tomé, Jean‐François Huneau, Dominique Hermier, Annie Quignard‐Boulangé	46
18	Quinoa Extract Enriched in 20‐Hydroxyecdysone Protects Mice From Diet‐Induced Obesity and Modulates Adipokines Expression 2011 ·Obesity ·(unknown), Véronique Mathé, René Lafont, Patrick C. Even, Waly Dioh, Stanislas Veillet, Daniel Tomé, Jean‐François Huneau, Dominique Hermier, Annie Quignard‐Boulangé	86
19	Combined genetic analysis of partial blast resistance in an upland rice population and recurrent selection for line and hybrid values 1996 ·Theoretical and Applied Genetics ·Stanislas Veillet, Marta Cristina Corsi de Filippi, A. Galláis	11
20	Combined genetic analysis of partial blast resistance in an upland rice population and recurrent selection for line and hybrid values 1996 ·Theoretical and Applied Genetics ·Stanislas Veillet, (unknown), (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact